Pharmacokinetic study of an injectable long-acting parenteral formulation of doxycycline hyclate in calves

Research in Veterinary Science

Volumn 84, Issue 3, 2008, Pages 477-482

  Vargas Estrada, D ^a   Gracia Mora, J ^a   Sumano, H ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Calves; Doxycycline; Pharmacokinetic; Sustained release

Indexed keywords

BETA CYCLODEXTRIN; DOXYCYCLINE HYCLATE; LONG ACTING DRUG; POLOXAMER;

ANIMAL EXPERIMENT; ARTICLE; CALF (BOVINE); COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INTERMITTENT THERAPY; DRUG SYNTHESIS; INJECTION SITE PAIN; INJECTION SITE SWELLING; MALE; MAXIMUM PLASMA CONCENTRATION; METHODOLOGY; NONHUMAN; SUSTAINED RELEASE FORMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; DELAYED-ACTION PREPARATIONS; DOXYCYCLINE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; KINETICS;

EID: 41749100600     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2007.07.003     Document Type: Article

References (39)

1. Abd A.M., Aty E.L., Goudaha A., and Zhoub H.H. Pharmacokinetics of doxycycline after administration as a single intravenous bolus and intramuscular doses to non-lactating Egyptian goats. Pharmacological Research 49 (2004) 487-491
2. Ailani R.K., Agastya G., Ailani R.K., Mukunda B.N., and Shekar R. Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia. Archives of Internal Medicine 159 (1999) 266-270
3. Aronson Al. Pharmacotherapeutics of the newer tetracyclines. Journal of the American Veterinary Medical Association 176 (1980) 1061-1068
4. Bekers O., Uijtendaal E.V., Beijnen J.H., Bult A., and Underberg W.J.M. Cyclodextrins in the pharmaceutical field. Drug development and Industrial Pharmacy 17 (1991) 1503-1549
5. Bennett J.V., Brodie J.L., Benner E.J., and Kirby W.M. Simplified, accurate method for antibiotic assay of clinical specimens. Applied Microbiology 14 (1966) 170-177
6. Boxenbaum H. Pharmacokinetics tricks and traps: flip-flop models. Journal of Pharmacy and Pharmaceutical Sciences 1 (1998) 90-91
7. Brook I., Elliott T.B., Pryor H.I., Sautter T.E., Gnade B.T., Thakar J.H., and Knudson G.B. In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones. International Journal of Antimicrobial Agents 18 (2001) 559-562
8. Chopra I., Howe T.G.B., Linton K.B., Richmond M.H., and Speller D.C.E. The tetracyclines: prospects at the beginning of the 1980s. Journal of Antimicrobial Chemotherapy 8 (1981) 5-21
9. Craig W. Pharmacokinetic-pharmacodynamic parameters: rationale for antibiotic use in mice and men. Clinical Infectious Diseases 26 (1998) 1-12
10. Cunha B.A., Sibley C.M., and Ristuccia A.M. Doxycycline. Therapeutic Drug Monitoring 4 (1982) 115-135
11. Gibaldi M., and Perrier D. Pharmacokinetics. second ed. (1982), Marcel Dekker, New York pp. 409-417
12. Gilbert J.C., Richardson J.L., Davies M.C., and Palin K.J. The effect of solutes and polymers on the gelation properties of pluronic F127 solutions for controlled drug delivery. Journal of Controlled Release 5 (1987) 113-118
13. Guerin-Faublee V., Flandrois J.P., Broye E., Tupin F., and Richard Y. Actinomyces pyogenes: susceptibility of 103 clinical animal isolates to 22 antimicrobial agents. Veterinary Research 24 (1993) 251-259
14. Hospenthal D.R., and Murray C.K. In vitro susceptibilities of seven Leptospira species to traditional and newer antibiotics. Antimicrobial Agents and Chemotherapy 47 (2003) 2646-2648
15. Inskeep P.B., and Darrington R.T. Controlled Release Veterinary Drug Delivery. In: Rathbone M.J., and Gurny R. (Eds) (2000), Elsevier Science B.V., Amsterdam 1-15
16. Jee J.B., Degraves F.J., Kim T.Y., and Kaltenboeck B. High prevalence of natural chlamydophila species infection in calves. Journal of Clinical Microbiology 42 (2004) 5664-5672
17. Kabanov A.V., Batrakova E.V., Melik-Nubarov N.S., Fedoseev N.A., Dorodnich T.Y., Alakhov V.Y., Chekonin V.P., and Nazarova I.R. A new class of drug carriers: micelles of poly(oxyethylene)-poly (oxypropylene)-poly (oxyethylene) block copolymers as microcontainers for drug targeting from blood in brain. Journal of Controlled Release 22 (1992) 141-158
18. Lawrence M.J. Surfactant systems microemulsions and vesicles as vehicles for drug delivery. European Journal of Drug and Pharmacokinetics 19 (1994) 257-259
19. Meijer L.A., Ceyssens K.G.F., De Greve B.I., and De Bruijn W. Pharmacokinetics and bioavailability of doxycycline hyclate after oral administration in calves. The Veterinary Quarterly 15 (1993) 1-5
20. Notari, R.E., 1980. In: Notari, R.E., (Ed.), Biopharmaceutics and Clinical Pharmacokinetics. An Introduction, third ed. Marcel Dekker, New York, pp. 45-212.
21. Ole-Mapenay I.M., and Mitema E.S. Some pharmacokinetic parameters of doxycycline in east African goats after intramuscular administration of a long acting formula. Veterinary Research Communications 19 (1995) 425-432
22. Ole-Mapenay I.M., Mitema E.S., and Mathio T.E. Aspects of pharmacokinetics of doxycycline given to healthy and pneumonic east African dwarf goats by intramuscular injection. Veterinary Research Communications 21 (1997) 453-462
23. Prescott J.F., Baggot J.D., and Walker R.D. Antimicrobial Therapy in Veterinary Medicine. third ed. (2000), Iowa State University Press, Ames Iowa, USA pp. 275-289
24. Riond J.L., and Riviere J.E. Pharmacokinetics and toxicology of doxycycline. Veterinary and Human Toxicology 30 (1988) 431-444
25. Riond J.L., and Riviere J.E. Doxycycline binding to plasma albumin of several species. Journal Veterinary Pharmacology Therapeutics 12 (1989) 253-260
26. Riond J.L., Tyezkowska K., and Riviere J.E. Pharmacokinetics and metabolic inertness of doxycycline in calves with mature or immature rumen function. American Journal of Veterinary Research 50 (1980) 1329-1332
27. Schmolka I.R. In: Tarcha P.J. (Ed). Polymers of Controlled Drug Delivery (1991), CRC Press, Boca Raton, FL 189-214
28. Shaw D.H., and Rubin S.T. Pharmacologic activity of doxycycline. Journal of the American Veterinary Medical Association 189 (1986) 808-810
29. Suzuka I., Kaji H., and Kaji A. Binding of specific sRNA to 30S ribosomal subunits: effects of 50S ribosomal subunits. Proceedings of the National Academy of Sciences of the United States of America 55 (1966) 1483-1486
30. Szejtli J. In: Smolen V.F., and Ball L.A. (Eds). Controlled Drug Bioavailability (1985), John-Wiley and sons, New York 365-421
31. Szeman J., Stadier-Szoke A., Vikmon M., and Szejtli J. Stabilization of prostaciclyn and furosemide by cyclodextrins. Chemical Abstracts 108 (1988) 392
32. Tarr B.D., and Yalkowsky S.H. A new parenteral vehicle for the administration of some poorly water soluble anti-cancer drugs. Journal of Parenteral Science and Technology 41 (1987) 31-33
33. Toutain P.L., and Bousquet-Mélou A. Bioavailability and its assessment. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 455-466
34. Uekama K., Hirayama F., and Irie T. Cyclodextrin drug carrier systems. Chemistry Reviews 98 (1998) 2045-2076
35. Vomand K.C., and Sumano L.H. Adverse drug reactions in cattle. Journal of the American Veterinary Medical Association 197 (1990) 899-905
36. Welling P.G. Pharmacokinetics, Processes, Mathematics and Applications. second ed. (1997), American Chemical Society, Washington, DC pp. 11-34
37. Yoshida A., Yamamoto M., Itoh T., Irie T., Hirayama F., and Uekama K. Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine. Chemical and Pharmaceutical Bulletin 38 (1990) 176-179
38. Yoshimura H., Ishimura M., Endoh Y.S., and Kojima A. Antimicrobial susceptibility of Pasteurella multocida isolated from cattle and pigs. Journal of Veterinary Medicine 48 (2001) 555-560
39. Ziv G., and Sulman F.G. Analysis of pharmacokinetic properties of nine tetracycline analogues in dairy cow and ewes. American Journal of Veterinary Research 35 (1974) 1197-1201